HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dyke, C. M. Articles by Salter, D. R. Search for Related Content PubMed PubMed Citation Articles by Dyke, C. M. Articles by Salter, D. R.

The Annals of Thoracic Surgery, Vol 52, 14-19, Copyright © 1991 by The Society of Thoracic Surgeons

ARTICLES

Triiodothyronine-enhanced left ventricular function after ischemic injury

CM Dyke, T Yeh Jr, JD Lehman, A Abd-Elfattah, M Ding, AS Wechsler and DR Salter
Department of Surgery, Medical College of Virginia, Virginia Commonwealth University, Richmond.

Hypothyroidism is associated with profound left ventricular dysfunction. Brain-dead organ donors and patients undergoing cardiopulmonary bypass are chemically hypothyroid with significantly reduced circulating free triiodothyronine (T3). To test the hypothesis that T3 enhances left ventricular function in a hormonally deficient environment, a total of 36 healthy New Zealand White rabbit hearts were studied using a modified Langendorff preparation with Krebs-Henseleit perfusate and intra-ventricular balloon. In 9 normal rabbit hearts a cumulative dose-response curve with logarithmically increasing doses of T3 was obtained. The vehicle solution for T3 dissolution served as control (n = 9). Left ventricular function was assessed from peak developed pressure at baseline and after T3 administration. Triiodothyronine had no effect in normal hearts on peak developed pressure or end-diastolic pressure. In 18 rabbits, the acute effect of T3 administration after ischemia was investigated. Preischemic left ventricular function was measured to serve as baseline, and hearts were subjected to 37 degrees C global ischemia. Triiodothyronine (n = 9) or vehicle (n = 9) was infused during reperfusion, and left ventricular peak developed pressure was measured at 30 and 60 minutes of reperfusion. Recovery of function (expressed as percent return of left ventricular peak developed pressure) was significantly improved within 15 minutes of reperfusion (65.0% +/- 2.1% versus 80.2% +/- 4.1%) and remained significantly improved throughout the reperfusion period (p less than 0.05 by analysis of variance). These data suggest that although T3 possesses no inotropic properties, it significantly improves postischemic left ventricular function. The rapidity of the functional improvement suggests that these effects may be due to plasma membrane-mediated mechanisms.

This article has been cited by other articles:

				P. Ferdinandy, R. Schulz, and G. F. Baxter Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning Pharmacol. Rev., December 1, 2007; 59(4): 418 - 458. [Abstract] [Full Text] [PDF]

				D. J. Kutsogiannis, G. Pagliarello, C. Doig, H. Ross, and S. D. Shemie Medical management to optimize donor organ potential: review of the literature: [Traitement medical pour optimaliser le potentiel de don d'organe : une revue documentaire]. Can J Anesth, August 1, 2006; 53(8): 820 - 830. [Abstract] [Full Text] [PDF]

				M. Sirlak, L. Yazicioglu, M. B. Inan, S. Eryilmaz, R. Tasoz, A. Aral, and U. Ozyurda Oral thyroid hormone pretreatment in left ventricular dysfunction Eur. J. Cardiothorac. Surg., October 1, 2004; 26(4): 720 - 725. [Abstract] [Full Text] [PDF]

				G. Iervasi, A. Pingitore, P. Landi, M. Raciti, A. Ripoli, M. Scarlattini, A. L'Abbate, and L. Donato Low-T3 Syndrome: A Strong Prognostic Predictor of Death in Patients With Heart Disease Circulation, February 11, 2003; 107(5): 708 - 713. [Abstract] [Full Text] [PDF]

				R. Salenger, J. S. Gammie, and T. J. Vander Salm Postoperative Care of Cardiac Surgical Patients Card. Surg. Adult, January 1, 2003; 2(2003): 439 - 469. [Full Text]

				M. Guden, B. Akpinar, E. Saggbas, I. Sanisoglu, E. Cakali, and O. Bayindir Effects of Intravenous Triiodothyronine During Coronary Artery Bypass Surgery Asian Cardiovasc Thorac Ann, September 1, 2002; 10(3): 219 - 222. [Abstract] [Full Text] [PDF]

				L. Friberg, S. Werner, G. Eggertsen, and S. Ahnve Rapid Down-regulation of Thyroid Hormones in Acute Myocardial Infarction: Is It Cardioprotective in Patients With Angina? Arch Intern Med, June 24, 2002; 162(12): 1388 - 1394. [Abstract] [Full Text] [PDF]

				A. U. Syed, A. F El Watidy, N B. Akhlaque, A. Wahba, R. M El Oakley, K. Imran, E. A Al Bukhari, and M. R Al Fagih Coronary Bypass Surgery in Patients on Thyroxin Replacement Therapy Asian Cardiovasc Thorac Ann, June 1, 2002; 10(2): 107 - 110. [Abstract] [Full Text] [PDF]

				S. L. Mullis-Jansson, M. Argenziano, S. Corwin, S. Homma, A. D. Weinberg, M. Williams, E. A. Rose, and C. R. Smith A RANDOMIZED DOUBLE-BLIND STUDY OF THE EFFECT OF TRIIODOTHYRONINE ON CARDIAC FUNCTION AND MORBIDITY AFTER CORONARY BYPASS SURGERY J. Thorac. Cardiovasc. Surg., June 1, 1999; 117(6): 1128 - 1135. [Abstract] [Full Text] [PDF]

				C. M. Dyke Triiodothyronine-Enhanced Left Ventricular Function After Ischemic Injury Ann. Thorac. Surg., October 1, 1998; 66(4): 1450 - 1451. [Full Text] [PDF]

				J. D. Klemperer, I. L. Klein, K. Ojamaa, R. E. Helm, M. Gomez, O. W. Isom, and K. H. Krieger Triiodothyronine Therapy Lowers the Incidence of Atrial Fibrillation After Cardiac Operations Ann. Thorac. Surg., May 1, 1996; 61(5): 1323 - 1327. [Abstract] [Full Text]

				J. D. Klemperer, I. Klein, M. Gomez, R. E. Helm, K. Ojamaa, S. J. Thomas, O. W. Isom, and K. Krieger Thyroid Hormone Treatment after Coronary-Artery Bypass Surgery N. Engl. J. Med., December 7, 1995; 333(23): 1522 - 1527. [Abstract] [Full Text] [PDF]

				M. G. Katz, A. J. Cohen, H. Schwalb, J. Segal, G. Merin, and A. Schachner Interaction of Thyroid Hormone and Heparin in Postischemic Myocardial Recovery Ann. Thorac. Surg., November 1, 1995; 60(5): 1215 - 1218. [Abstract] [Full Text]

				J. D. Walker, F. A. Crawford Jr., R. Mukherjee, and F. G. Spinale THE DIRECT EFFECTS OF 3,5,3'-TRIIODO-L-THYRONINE (T3) ON MYOCYTE CONTRACTILE PROCESSES: Insights into mechanisms of action J. Thorac. Cardiovasc. Surg., November 1, 1995; 110(5): 1369 - 1380. [Abstract] [Full Text]

				J. D. Walker, F. A. Crawford Jr, and F. G. Spinale 3,5,3'Triiodo-L-Thyronine Pretreatment With Cardioplegic Arrest and Chronic Left Ventricular Dysfunction Ann. Thorac. Surg., August 1, 1995; 60(2): 292 - 299. [Abstract] [Full Text]

				J. D. Walker, F. A. Crawford, and F. G. Spinale PRETREATMENT WITH 3,5,3' TRIIODO-L-THYRONINE (T3): Effects on myocyte contractile function after hypothermic cardioplegic arrest and rewarming J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 315 - 327. [Abstract] [Full Text]

				J. D. Klemperer, J. Zelano, R. E. Helm, K. Berman, K. Ojamaa, I. Klein, O. W. Isom, and K. Krieger Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemia J. Thorac. Cardiovasc. Surg., March 1, 1995; 109(3): 457 - 465. [Abstract] [Full Text]

				B. Murzi, G. Iervasi, S. Masini, R. Moschetti, V. Vanini, G. Zucchelli, and A. Biagini Thyroid Hormones Homeostasis in Pediatric Patients During and After Cardiopulmonary Bypass Ann. Thorac. Surg., February 1, 1995; 59(2): 481 - 485. [Abstract] [Full Text]

				J. D. Walker, F. A. Crawford, S. Kato, and F. G. Spinale The novel effects of 3,5,3'-triiodo-L-thyronine on myocyte contractile function and {beta}-adrenergic responsiveness in dilated cardiomyopathy J. Thorac. Cardiovasc. Surg., October 1, 1994; 108(4): 672 - 679. [Abstract] [Full Text]